ArticleJournal of clinical medicine2024

Effects of Combination Therapy with Intravitreal Ranibizumab and Tissue Plasminogen Activator for Neovascular Age-Related Macular Degeneration.

Michiko Ando et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.